Cryo-Cell Intl Inc (CCEL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 11/30
| 05-2024 | 02-2024 | 11-2023 | 08-2023 | 05-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 469 | 247 | 406 | 584 | 1,124 |
| Marketable Securities | 1,060 | 733 | 574 | 624 | 568 |
| Receivables | 6,831 | 6,727 | 6,576 | 6,438 | 6,683 |
| Inventories | 708 | 755 | 769 | 1,063 | 879 |
| Other current assets | 436 | 455 | 512 | 509 | 409 |
| TOTAL | $10,157 | $9,452 | $9,453 | $9,936 | $10,314 |
| Non-Current Assets | |||||
| PPE Net | 22,162 | 21,605 | 20,997 | 18,837 | 17,098 |
| Investments And Advances | 0 | 308 | 308 | 308 | 308 |
| Intangibles | 2,897 | 2,914 | 2,931 | 16,303 | 16,567 |
| Other Non-Current Assets | 27,352 | 27,432 | 27,533 | 24,413 | 24,471 |
| TOTAL | $52,410 | $52,259 | $51,768 | $59,860 | $58,444 |
| Total Assets | $62,567 | $61,711 | $61,221 | $69,796 | $68,758 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 4,223 | 1,973 | 1,223 | 2,723 | 1,773 |
| Accounts payable and accrued liabilities | 1,828 | 2,997 | 3,175 | 2,786 | 4,056 |
| Accrued Expenses | 3,217 | 3,917 | 5,171 | 1,775 | 2,217 |
| Other current liabilities | 133 | 667 | 1,200 | 1,200 | 1,824 |
| TOTAL | $19,448 | $19,370 | $20,864 | $18,563 | $19,708 |
| Non-Current Liabilities | |||||
| Long Term Debt | 8,356 | 8,392 | 8,430 | 8,468 | 8,506 |
| Deferred Revenues | 9,581 | 9,395 | 9,705 | 9,697 | 9,456 |
| Other Non-Current Liabilities | 1,583 | 1,683 | 1,771 | 2,815 | 2,750 |
| TOTAL | $53,860 | $52,678 | $51,388 | $51,250 | $49,908 |
| Total Liabilities | $73,308 | $72,049 | $72,252 | $69,813 | $69,616 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 8,062 | 8,104 | 8,287 | 8,287 | 8,288 |
| Common Shares | 149 | 149 | 149 | 149 | 149 |
| Retained earnings | -29,947 | -30,603 | -31,159 | -19,969 | -20,650 |
| Other shareholders' equity | 161 | 398 | -432 | -432 | -424 |
| TOTAL | $-10,741 | $-10,338 | $-11,031 | $-16 | $-858 |
| Total Liabilities And Equity | $62,567 | $61,711 | $61,221 | $69,796 | $68,758 |